Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K.A. Blum

Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)

Hematological Oncology

English

Beyond Maximum Grade: A Novel, Longitudinal Toxicity Over Time (Toxt) Adverse Event Analysis of Lenalidomide in Follicular Lymphoma in Calgb 50401 (Alliance)

Hematological Oncology

English

Related publications

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

British Journal of Haematology

Hematology

2018

English

Autologous Stem Cell Transplantation Is Infrequently Utilized but Associated With Improved Overall Survival in Elderly Patients With Mantle Cell Lymphoma

Hematological Oncology

English

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

English

Rituximab Maintenance After Nordic Protocol (R-Maxichop/Hd-Arac/Asct) Significantly Prolongs Survival in Young Mantle Cell Lymphoma Patients

Hematological Oncology

English

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

American Journal of Hematology

Hematology

2018

English

Rituximab Alone (R) Versus Rituximab Plus Bendamustine (Br) for Splenic (Smzl) and Nodal Marginal Zone Lymphoma (Nmzl)

Hematological Oncology

English

Chronic Hepatitis E in Patients With Indolent Lymphoma After Treatment With Rituximab and Bendamustine

English

A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT-NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA

Hematological Oncology

English

Rituximab Is Associated With Improved Survival in Burkitt Lymphoma: A Retrospective Analysis From Two US Academic Medical Centers

Therapeutic Advances in Hematology

Hematology

2013

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by K.A. Blum

Maintenance Rituximab Is Associated With Improved Overall Survival in Mantle Cell Lymphoma Patients Responding to Induction Therapy With Bendamustine + Rituximab (Br)

Beyond Maximum Grade: A Novel, Longitudinal Toxicity Over Time (Toxt) Adverse Event Analysis of Lenalidomide in Follicular Lymphoma in Calgb 50401 (Alliance)

Related publications

Maintenance Rituximab or Observation After Frontline Treatment With Bendamustine-Rituximab for Follicular Lymphoma

Autologous Stem Cell Transplantation Is Infrequently Utilized but Associated With Improved Overall Survival in Elderly Patients With Mantle Cell Lymphoma

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Rituximab Maintenance After Nordic Protocol (R-Maxichop/Hd-Arac/Asct) Significantly Prolongs Survival in Young Mantle Cell Lymphoma Patients

Rituximab, Bendamustine and Cytarabine (R-Bac) in Patients With Relapsed-Refractory Aggressive B-Cell Lymphoma

Rituximab Alone (R) Versus Rituximab Plus Bendamustine (Br) for Splenic (Smzl) and Nodal Marginal Zone Lymphoma (Nmzl)

Chronic Hepatitis E in Patients With Indolent Lymphoma After Treatment With Rituximab and Bendamustine

A PHASE 3 STUDY OF ACALABRUTINIB PLUS BENDAMUSTINE AND RITUXIMAB IN ELDERLY (AGED ≥65 Years) TREATMENT-NAIVE PATIENTS WITH MANTLE CELL LYMPHOMA

Rituximab Is Associated With Improved Survival in Burkitt Lymphoma: A Retrospective Analysis From Two US Academic Medical Centers